Business Standard

Sunday, December 22, 2024 | 09:25 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Brawn Biotech standalone net profit declines 76.47% in the September 2020 quarter

Image

Capital Market

Sales decline 18.35% to Rs 9.70 crore

Net profit of Brawn Biotech declined 76.47% to Rs 0.08 crore in the quarter ended September 2020 as against Rs 0.34 crore during the previous quarter ended September 2019. Sales declined 18.35% to Rs 9.70 crore in the quarter ended September 2020 as against Rs 11.88 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales9.7011.88 -18 OPM %1.033.62 -PBDT0.090.44 -80 PBT0.080.43 -81 NP0.080.34 -76

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 10 2020 | 4:24 PM IST

Explore News